Insider Cluster (3 insiders) ·Filed Mar 30, 2026

NUVL

Nuvalent, Inc.
BEARISH
Impact 7/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $1.8M total
Actionable Insight ▼ Bearish

Traders should watch for potential downward pressure on NUVL shares, particularly given the CEO's large sale immediately following option exercises. This pattern may signal lack of confidence in near-term upside, especially in a high-growth biotech where executives typically hold long-term equity. Monitor upcoming earnings or pipeline updates for catalysts that could justify or counter this selling.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
NUVL ▲ +27.72% at T+60d
SHORT call ✗ call lost -27.72% · α vs SPY -11.23% · entry $96.72 → $123.53
Entry anchored
Mar 27, 03:59 PM ET
via exchange tick
T+1d
+5.92%
call -5.92% · α -3.03%
$102.45
settled 6mo ago
T+5d
+5.72%
call -5.72% · α -1.42%
$102.25
settled 6mo ago
T+20d
+5.40%
call -5.40% · α +7.20%
$101.94
settled 5mo ago
T+60d
+27.72%
call -27.72% · α -11.23%
$123.53
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Nuvalent CEO and CFO sold shares worth $1.79M in a coordinated cluster over the past week, with the CEO selling $1.17M and exercising options worth $259K. The transactions represent a material insider selling event involving top leadership.

Key Financial Metrics

Direction
selling
Total Value
$1.8M
Insiders
3

Key Facts

  • CEO James Richard Porter sold 11,354 shares for $1.17M and exercised 27,428 derivative shares (two tranches of 13,714) at $18.93, realizing $259,606 in value.
  • CFO Alexandra Balcom sold 3,500 shares for $370,365.
  • Chief Development Officer Darlene Noci sold 2,500 shares for $247,000.
  • Total open-market sales: $1.79M over a 7-day window, representing ~0.022% of $8.0B market cap.
  • All three transactions were reported under Form 4 with code 'S' (open-market sale).

Financial Impact

$1.79M in net insider selling over 7 days

insider ownershipmarket sentimentshareholder dilution perception

Risk Factors

  • Insider selling concentrated among C-suite executives, including CEO and CFO, increasing signal strength.
  • Risk of negative market perception around equity monetization after stock run-up, potentially dampening investor sentiment.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NUVL-1775680253361
18 reports for NUVL
Performance horizon
43% Hit rate 3 of 7 directional calls best @ T+60▲ +21.01%Apr 7, 2026
Filters
Rows
Reports for NUVL — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
15-12G
NEUTRAL ★ 3/10
—awaiting T+5——
Jul 15, 2026
11w ago
25-NSE
NEUTRAL ★ 3/10
$123.96 $123.96· 0.00%▲ +0.98%—
Jul 15, 2026
11w ago
8-K
BULLISH ★ 5/10
$123.96 $123.96· 0.00%▲ +0.98%—
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.80 $123.96▲ +0.13%▼ −0.73%—
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.72 $123.90▲ +0.15%▼ −0.34%—
Jun 11, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$123.25 $123.43▲ +0.15%▼ −0.53%—
Jun 10, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$123.45 $123.36▼ −0.07%▼ −0.51%—
Jun 9, 2026
16w ago
8-K
BULLISH ★ 8/10
$123.25 $123.35▲ +0.08%▼ −2.33%—
May 7, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$102.40 $105.22▲ +2.75%▲ +1.25%—
Apr 29, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$99.10 $101.47▲ +2.39%▼ −0.72%—
Showing 10 of 18

US Market Status

Market Open — Closes in 3h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 8, 2026